StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
BHAVIK.BO$161.00-1.83%
Fair $161.00+0.0%

BHAVIK.BO

Bhavik Enterprises Limited

Basic Materials / Specialty ChemicalsBSE

$161.00

-3.00 (-1.83%)

Fairly Valued+0.0%Fair Value $161.00Fund rank 21/100 · Data gapFallback financials|
SA 31/D
F-Score: 1/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $-27.8M · quality 28.0/100

Data gap 21/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 14/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

31/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · BHAVIK.BOLocal privado en este navegador · Bhavik Enterprises Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.3B

P/E

57.7x

↑

EV/EBITDA

N/A

•

ROE

5.8%

↑

Gross Margin

1.6%

↓

Debt/Equity

N/A

•
52-Week Range$161
$121$175

TradingView lightweight chart

BHAVIK.BO price, volumen y niveles de valoración

Último $161.00Periodo +10.8%
Fair value: $161.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+22.9%

FCF CAGR

—

FCF margin

-7.0%

FCF / Net income

-6.51x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $5.27B · net income $56.8M · FCF $-369.7M

2022-FY → 2025-FY

Gross margin

1.6%-1.8% pts

Operating margin

0.7%-1.5% pts

Net margin

1.1%-1.3% pts

FCF margin

-7.0%-7.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$5.27B$5.27B$4.94B$4.87B$2.84B
Net Income$56.8M$56.8M$78.9M$155.6M$67.6M
EBITDA$78.9M$78.9M$108.9M$209.5M$92.1M
EPS——3.887.643.32
Gross Margin1.6%1.6%1.9%4.5%3.3%
Operating Margin0.7%0.7%0.9%3.6%2.2%
Net Margin1.1%1.1%1.6%3.2%2.4%
Balance Sheet
Current Ratio3.253.25———
Cash Flow
Free Cash Flow$-369.7M$-369.7M$-27.8M$106.5M$5.0M
Returns
ROE5.8%5.8%8.5%18.4%9.8%
Valuation
P/E57.7157.71———
Growth & Yield
Revenue Growth6.7%6.7%1.4%71.7%—
EPS Growth——-49.3%130.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total +10.8%

Total return

+10.8%

Start / end P/E

n/dx → n/dx

EPS bridge

3.88 → n/d

Residual

+10.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+10.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.